$79.54
-0.24-0.30%
In chiusura: -
$79.54
N/A
After hour: Nov 7, 4:00 PM EDT
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Protagonist Therapeutics. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Protagonist Therapeutics.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Protagonist Therapeutics Inc addetti ai lavori?
A Protagonist Therapeutics Inc, la recente attività interna ha attirato l'attenzione. Negli ultimi 30 giorni, gli addetti ai lavori hanno riferito di aver venduto un totale di - azioni del valore di -, nel frattempo, gli addetti ai lavori hanno segnalare nessun acquisto negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
- Il giorno agosto 29, 2025, William D Waddill, l'azienda DIRECTOR sold 4K condivisioni per $59.25 ciascuna.
- Il giorno settembre 24, 2025, William D Waddill, l'azienda DIRECTOR sold 4K condivisioni per $64.25 ciascuna.
Statistiche sulla proprietà per Protagonist Therapeutics Inc
Numero di azioni emesse
62.211M
Azioni possedute dagli insider
1.279M
Percentuale posseduta dagli Insider
2.06%
Azioni possedute dagli investitori istituzionali
28.417M
Percentuale posseduta dagli investitori istituzionali
45.7%
Oct 14, 2025 | DIRECTOR | 0.00 | $44.30 | -$895.72K | SELL-OPTIONS | 0.00% | 5.13K | Oct 10 | ||
Sep 24, 2025 | DIRECTOR | -4.00K | $64.25 | -$257.00K | SELL | -43.81% | 5.13K | Sep 22 | ||
Aug 29, 2025 | DIRECTOR | -4.00K | $59.25 | -$237.00K | SELL | -30.46% | 9.13K | Aug 27 | ||
Jul 28, 2025 | PRESIDENT AND CEO | -10.41K | $54.78 | -$570.53K | SELL | -1.96% | 520.60K | Jul 25 | ||
Jul 23, 2025 | PRESIDENT AND CEO | -27.44K | $54.92 | -$2.88M | SELL | -4.91% | 531.02K | Jul 21 - Jul 23 | ||
Jun 11, 2025 | CHIEF MEDICAL OFFICER | 0.00 | $32.16 | -$964.60K | SELL-OPTIONS | 0.00% | 83.89K | Jun 09 - Jun 10 | ||
Apr 23, 2025 | CHIEF FINANCIAL OFFICER | -1.76K | $46.00 | -$80.78K | SELL | -2.80% | 61.06K | Apr 22 | ||
Mar 19, 2025 | DIRECTOR | -4.00K | $54.25 | -$217.00K | SELL | -23.35% | 13.13K | Mar 17 | ||
Mar 14, 2025 | CHIEF MEDICAL OFFICER | 0.00 | $40.11 | -$953.89K | SELL-OPTIONS | 0.00% | 83.89K | Mar 13 | ||
Mar 14, 2025 | CHIEF FINANCIAL OFFICER | 0.00 | $36.82 | -$1.09M | SELL-OPTIONS | 0.00% | 62.82K | Mar 12 | ||
Feb 20, 2025 | PRESIDENT AND CEO | -5.36K | $38.18 | -$204.61K | SELL | -0.98% | 540.26K | Feb 19 | ||
Jan 17, 2025 | CHIEF MEDICAL OFFICER | -3.64K | $0.00 | $0.00 | SELL | -4.16% | 83.89K | Jan 16 | ||
Jan 17, 2025 | CHIEF FINANCIAL OFFICER | -3.92K | $0.00 | $0.00 | SELL | -5.87% | 62.82K | Jan 16 | ||
Nov 27, 2024 | CHIEF MEDICAL OFFICER | 0.00 | $26.45 | -$1.16M | SELL-OPTIONS | 0.00% | 46.44K | Nov 26 - Nov 27 | ||
Nov 27, 2024 | CHIEF DEVELOPMENT OFFICER | 82.82K | $27.18 | -$3.91M | SELL-OPTIONS | 44.86% | 267.43K | Nov 25 - Nov 26 | ||
Nov 27, 2024 | PRESIDENT AND CEO | -105.27K | $34.19 | -$4.64M | SELL | -20.49% | 408.45K | Nov 25 - Nov 26 | ||
Nov 19, 2024 | CHIEF MEDICAL OFFICER | -1.91K | $40.98 | -$78.11K | SELL | -3.94% | 46.44K | Nov 15 | ||
Sep 13, 2024 | CHIEF FINANCIAL OFFICER | -2.20K | $30.08 | -$443.71K | SELL | -5.93% | 34.96K | Sep 11 | ||
Sep 12, 2024 | DIRECTOR | 0.00 | $28.94 | -$256.96K | SELL-OPTIONS | 0.00% | 12.00K | Sep 10 | ||
Jul 26, 2024 | DIRECTOR | 0.00 | $26.44 | -$216.96K | SELL-OPTIONS | 0.00% | 12.00K | Jul 24 | ||
Jun 11, 2024 | DIRECTOR | 0.00 | $23.94 | -$176.96K | SELL-OPTIONS | 0.00% | 12.00K | Jun 07 | ||
Jun 11, 2024 | PRESIDENT AND CEO | -35.00K | $35.19 | -$1.23M | SELL | -6.36% | 515.41K | Jun 07 | ||
Apr 19, 2024 | CHIEF FINANCIAL OFFICER | -1.23K | $25.11 | -$30.99K | SELL | -3.21% | 37.16K | Apr 18 | ||
Apr 02, 2024 | PRESIDENT AND CEO | -25.00K | $28.31 | -$707.75K | SELL | -4.35% | 549.59K | Apr 01 | ||
Mar 01, 2024 | PRESIDENT AND CEO | -30.00K | $31.62 | -$948.60K | SELL | -4.96% | 574.59K | Mar 01 | ||
Mar 01, 2024 | DIRECTOR | 0.00 | $18.71 | -$327.62K | SELL-OPTIONS | 0.00% | 12.00K | Mar 01 | ||
Mar 01, 2024 | CHIEF FINANCIAL OFFICER | -12.19K | $21.89 | -$618.33K | SELL | -24.09% | 38.40K | Feb 29 - Mar 01 | ||
Jan 11, 2024 | CHIEF DEVELOPMENT OFFICER | 0.00 | $16.19 | -$88.10K | SELL-OPTIONS | 0.00% | 187.57K | Jan 09 | ||
Jan 04, 2024 | CHIEF MEDICAL OFFICER | 24.40K | $16.24 | -$30.01K | GRANT | 100.11% | 48.78K | Nov 15 - Jan 02 | ||
Dec 15, 2023 | PRESIDENT AND CEO | -75.00K | $20.08 | -$1.51M | SELL | -12.31% | 534.35K | Dec 13 | ||
Dec 23, 2021 | PRESIDENT AND CEO | -15.00K | $32.14 | -$482.17K | SELL | -3.05% | 477.16K | Dec 21 | ||
Aug 19, 2021 | CHIEF SCIENTIFIC OFFICER | -4.78K | $24.21 | -$694.19K | SELL | -7.58% | 58.25K | Aug 17 | ||
Feb 12, 2021 | DIRECTOR | 0.00 | $16.14 | -$153.92K | GRANT | 0.00% | 0.00 | Feb 10 - Feb 11 | ||
Jan 20, 2021 | PRESIDENT AND CEO | -11.85K | $14.40 | -$556.37K | SELL | -2.70% | 426.14K | Jan 19 | ||
Aug 12, 2020 | — | 0.00 | $9.54 | -$38.23K | OPTION EXERCISE | 0.00% | 0.00 | Aug 11 | ||
Mar 12, 2020 | — | 12.00K | $6.70 | $80.40K | PURCHASE | 362.54% | 15.31K | Mar 12 | ||
Dec 03, 2019 | DIRECTOR | 8.00K | $5.70 | $45.62K | BUY | 80.00% | 18.00K | Dec 03 | ||
Dec 03, 2019 | EVP CLINICAL OPERATIONS | 30.00K | $5.13 | $153.90K | BUY | 153.85% | 49.50K | Dec 03 | ||
Dec 03, 2019 | CHIEF FINANCIAL OFFICER | 1.18K | $5.10 | $5.99K | BUY | ∞ | 1.18K | Dec 03 | ||
Dec 03, 2019 | PRESIDENT AND CEO | 30.00K | $5.62 | $168.50K | BUY | 7.90% | 409.82K | Dec 03 | ||
Aug 08, 2019 | CHIEF SCIENTIFIC OFFICER | -3.40K | $8.85 | -$30.04K | SELL | -6.38% | 49.80K | Aug 06 | ||
Aug 08, 2019 | PRESIDENT AND CEO | -10.79K | $8.85 | -$95.54K | SELL | -2.80% | 374.79K | Aug 06 | ||
Mar 04, 2019 | CHIEF SCIENTIFIC OFFICER | 14.19K | $8.03 | -$6.50K | GRANT | 38.34% | 51.20K | Feb 28 - Mar 01 | ||
Mar 04, 2019 | PRESIDENT AND CEO | 26.57K | $8.03 | -$17.53K | GRANT | 7.44% | 383.83K | Feb 28 - Mar 01 | ||
Mar 04, 2019 | CHIEF MEDICAL OFFICER | 7.84K | $8.03 | -$5.28K | GRANT | 32.44% | 32.02K | Feb 28 - Mar 01 | ||
Feb 08, 2019 | PRESIDENT AND CEO | -10.91K | $7.74 | -$84.41K | SELL | -2.96% | 357.26K | Feb 06 | ||
Feb 08, 2019 | CHIEF SCIENTIFIC OFFICER | -3.82K | $7.74 | -$29.56K | SELL | -9.36% | 37.01K | Feb 06 | ||
Feb 08, 2019 | CHIEF MEDICAL OFFICER | -2.78K | $7.74 | -$21.51K | SELL | -10.31% | 24.18K | Feb 06 | ||
May 21, 2018 | 10% OWNER | -38.97K | $6.09 | -$237.36K | SELL | -1.81% | 2.12M | May 17 | ||
May 17, 2018 | DIRECTOR | 10.00K | $6.46 | $64.57K | BUY | ∞ | 10.00K | May 16 | ||
May 16, 2018 | 10% OWNER | -164.75K | $6.42 | -$1.06M | SELL | -7.10% | 2.16M | May 14 - May 16 | ||
Mar 26, 2018 | 10% OWNER | -59.95K | $20.71 | -$1.24M | SELL | -2.52% | 2.32M | Mar 23 | ||
Mar 22, 2018 | 10% OWNER | -39.52K | $20.61 | -$814.40K | SELL | -1.63% | 2.38M | Mar 20 - Mar 22 | ||
Mar 19, 2018 | 10% OWNER | -20.36K | $20.55 | -$418.51K | SELL | -0.83% | 2.42M | Mar 16 - Mar 19 | ||
Mar 15, 2018 | 10% OWNER | -13.15K | $20.66 | -$271.77K | SELL | -0.54% | 2.44M | Mar 13 - Mar 15 | ||
Mar 13, 2018 | CHIEF SCIENTIFIC OFFICER | 0.00 | $12.75 | -$59.76K | SELL-OPTIONS | 0.00% | 15.03K | Mar 12 | ||
Mar 02, 2018 | CHIEF SCIENTIFIC OFFICER | 9.50K | $10.95 | -$15.85K | SELL-OPTIONS | 248.56% | 13.32K | Feb 28 - Mar 02 | ||
Jan 17, 2018 | CHIEF SCIENTIFIC OFFICER | 0.00 | $10.95 | -$15.85K | SELL-OPTIONS | 0.00% | 3.82K | Jan 16 | ||
Dec 27, 2017 | CHIEF MEDICAL OFFICER | 0.00 | $12.36 | -$57.49K | SELL-OPTIONS | 0.00% | 0.00 | Dec 22 | ||
Dec 21, 2017 | PRESIDENT AND CEO | 0.00 | $10.72 | -$145.05K | SELL-OPTIONS | 0.00% | 190.44K | Dec 21 | ||
Dec 20, 2017 | PRESIDENT AND CEO | 0.00 | $10.72 | -$31.60K | SELL-OPTIONS | 0.00% | 190.44K | Dec 20 | ||
Dec 20, 2017 | CHIEF SCIENTIFIC OFFICER | 0.00 | $10.95 | -$15.85K | SELL-OPTIONS | 0.00% | 3.82K | Dec 18 | ||
Dec 20, 2017 | CHIEF FINANCIAL OFFICER | 0.00 | $11.34 | -$138.52K | SELL-OPTIONS | 0.00% | 0.00 | Dec 18 | ||
Dec 01, 2017 | CHIEF SCIENTIFIC OFFICER | 0.00 | $10.95 | -$15.85K | GRANT | 0.00% | 3.82K | Nov 30 | ||
Nov 15, 2017 | CHIEF SCIENTIFIC OFFICER | 0.00 | $10.01 | -$97.41K | SELL-OPTIONS | 0.00% | 3.82K | Nov 13 | ||
Oct 10, 2017 | CHIEF MEDICAL OFFICER | 0.00 | $11.61 | -$29.83K | SELL-OPTIONS | 0.00% | 0.00 | Oct 05 | ||
Sep 12, 2017 | CHIEF MEDICAL OFFICER | -3.69K | $14.31 | -$52.75K | SELL | -100.00% | 0.00 | Sep 12 | ||
Aug 30, 2017 | CHIEF MEDICAL OFFICER | 0.00 | $10.61 | -$19.34K | SELL-OPTIONS | 0.00% | 1.86K | Aug 29 | ||
Aug 29, 2017 | CHIEF SCIENTIFIC OFFICER | 0.00 | $9.61 | -$37.77K | SELL-OPTIONS | 0.00% | 2.00K | Aug 28 | ||
Jul 12, 2017 | CHIEF SCIENTIFIC OFFICER | 0.00 | $7.29 | -$37.77K | SELL-OPTIONS | 0.00% | 2.00K | Jul 10 | ||
Aug 18, 2016 | 10% OWNER | 2.45M | $12.00 | $7.00M | BUY | ∞ | 2.45M | Aug 16 | ||
Aug 16, 2016 | DIRECTOR | 2.45M | $12.00 | $7.00M | BUY | ∞ | 2.45M | Aug 16 | ||
Aug 16, 2016 | DIRECTOR | 2.45M | $12.00 | $7.00M | BUY | ∞ | 2.45M | Aug 16 | ||
Aug 16, 2016 | DIRECTOR | 2.10M | $12.00 | $7.00M | BUY | ∞ | 2.10M | Aug 16 | ||
Aug 16, 2016 | 10% OWNER | 2.10M | $12.00 | $7.00M | BUY | ∞ | 2.10M | Aug 16 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.